The Michigan Supreme Court will decide whether to overturn past precedent to clear the way for an attorney general probe into ...

The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive control merely drives patients underground. Regulation should protect safety, not ...

IF you’ve ever searched for weight loss tips online, you will know the deep rabbit hole that awaits. But now, social media ...

EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...

A nonprofit founded by members of the Lilly family has been unloading Eli Lilly stock nearly every day since the start of the month.

Walmart will offer in‑store pickup of Eli Lilly’s discounted weight‑loss drug Zepbound, giving self‑pay customers easier, ...

Reuters further highlighted that Novo Nordisk A/S (NYSE:NVO), which initially celebrated the success of its obesity drug, has ...

Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...

"GLP-1RA microdosing trend continues despite “anecdotal evidence”" was originally created and published by Pharmaceutical ...

Dubbed the 'world's biggest raid', it was also the first illicit production facility for weight loss medicine discovered in ...

Eli Lilly has partnered with Cipla to market its weight-loss drug tirzepatide in India under the brand name Yurpeak, offering weekly injectable doses to expand access to obesity care.

Under the agreement, Cipla will market the drug under a new brand name, Yurpeak, while Lilly continues to sell it as Mounjaro ...